The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2020

Filed:

Nov. 23, 2012
Applicants:

Chanel Parfums Beaute, Neuilly sur Seine, FR;

Leiden University Medical Center, Leiden, NL;

Inventors:

Gaelle Saintigny, Pantin, FR;

Abdelouahab Elghalbzouri, Leiden, NL;

Assignees:

CHANEL PARFUMS BEAUTE, Neuilly sur Seine, FR;

LEIDEN UNIVERSITY MEDICAL CENTER, Leiden, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6876 (2018.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6876 (2013.01); G01N 33/5023 (2013.01); G01N 33/5044 (2013.01); G01N 33/56966 (2013.01); G01N 2333/4728 (2013.01); G01N 2800/7042 (2013.01);
Abstract

An in vitro method for screening for candidate compounds for preventing and/or attenuating skin ageing, and/or hydrating skin, includes: a) contacting a test compound with a sample of papillary fibroblasts; b) measuring the expression of a gene selected from PDPN, CCRL1 and NTN1, in the papillary fibroblasts; and c) selecting compounds for which an activation of at least 1.5 fold of the expression of at least one of the genes is measured in the treated papillary fibroblasts compared with untreated papillary fibroblasts. Another in vitro method includes: a) contacting a test compound with a sample of reticular fibroblasts; b) measuring the expression of a gene selected from MGP, PPP1R14A and TGM2, in the reticular fibroblasts; and c) selecting compounds for which an activation of at most 1.0 fold of the expression of at least one of the genes is measured in the treated reticular fibroblasts compared with untreated reticular fibroblasts.


Find Patent Forward Citations

Loading…